Literature DB >> 19423525

Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates.

Sabine Rohrmann1, Catherine G Sutcliffe, Jessica L Bienstock, Deborah Monsegue, Folasade Akereyeni, Gary Bradwin, Nader Rifai, Michael N Pollak, Tanya Agurs-Collins, Elizabeth A Platz.   

Abstract

BACKGROUND: To address whether umbilical cord blood concentrations of sex steroid hormones and the insulin-like growth factor (IGF) axis differ between African-American and White male neonates.
METHODS: In 2004 and 2005, venous cord blood samples were collected from 75 African-American and 38 White male full-term uncomplicated births along with birth weight, placental weight, mother's age and parity, and time of birth. Testosterone, androstanediol glucuronide, estradiol, and sex hormone binding globulin (SHBG) were measured by immunoassay, and IGF-I, IGF-2, and IGF binding protein (BP)-3 by ELISA. Crude and multivariable-adjusted geometric mean concentrations were computed.
RESULTS: Androstanediol glucuronide, estradiol, and SHBG concentrations did not differ by race; however, the molar ratio of testosterone to SHBG was higher in African-American than White male babies after adjustment (P = 0.01). Both before and after adjustment, Whites had higher concentrations of IGF-I (adjusted; White, African-American, 93.1, 71.9 ng/mL), IGF-2 (537.3-474.8 ng/mL), and IGFBP-3 (1,673-1,482 ng/mL) than African-Americans (P < 0.05), although the molar ratio of IGF-I plus IGF-2 to IGFBP-3 did not differ by race.
CONCLUSION: The higher cord blood testosterone to SHBG ratio in African-American compared with White male babies after taking into account maternal and birth factors is compatible with the hypothesis that differences in androgen levels in utero contribute to their higher prostate cancer risk, although we would have expected crude differences as well. Lower cord blood IGF-I and IGF-2 levels in African-American compared with White male babies are not consistent with the hypothesis that differences in growth factor levels contribute to their higher prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423525      PMCID: PMC3012385          DOI: 10.1158/1055-9965.EPI-08-0817

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  41 in total

1.  Serum testosterone levels in African-American and white men undergoing prostate biopsy.

Authors:  W S Kubricht; B J Williams; T Whatley; P Pinckard; J A Eastham
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

Review 2.  Insulin-like growth factor axis during embryonic development.

Authors:  G J Allan; D J Flint; K Patel
Journal:  Reproduction       Date:  2001-07       Impact factor: 3.906

Review 3.  A new model for the origins of chronic disease.

Authors:  D J Barker
Journal:  Med Health Care Philos       Date:  2001

4.  Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  K Ong; J Kratzsch; W Kiess; M Costello; C Scott; D Dunger
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

5.  Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Authors:  E A Platz; M N Pollak; E B Rimm; N Majeed; Y Tao; W C Willett; E Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

6.  Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study.

Authors:  O Ukkola; J Gagnon; T Rankinen; P A Thompson; Y Hong; A S Leon; D C Rao; J S Skinner; J H Wilmore; C Bouchard
Journal:  Eur J Endocrinol       Date:  2001-07       Impact factor: 6.664

7.  Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study.

Authors:  T Forsén; J G Eriksson; J Tuomilehto; C Osmond; D J Barker
Journal:  BMJ       Date:  1999-11-27

8.  Size at birth, childhood growth and obesity in adult life.

Authors:  J Eriksson; T Forsén; J Tuomilehto; C Osmond; D Barker
Journal:  Int J Obes Relat Metab Disord       Date:  2001-05

9.  Early growth, adult income, and risk of stroke.

Authors:  J G Eriksson; T Forsén; J Tuomilehto; C Osmond; D J Barker
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

10.  Duration of gestation and prostate cancer risk in offspring.

Authors:  A Ekbom; J Wuu; H O Adami; C M Lu; P Lagiou; D Trichopoulos; C Hsieh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-02       Impact factor: 4.254

View more
  25 in total

1.  To adjust or not in studies on racial differences in hormone concentrations? Depends on the question!

Authors:  Sabine Rohrmann; Elizabeth A Platz
Journal:  J Clin Endocrinol Metab       Date:  2013-11-25       Impact factor: 5.958

2.  Correlation of Insulin-Like Growth Factor-I and -II Concentrations at Birth Measured by Mass Spectrometry and Growth from Birth to Two Months.

Authors:  Colin P Hawkes; Deirdre M Murray; Louise C Kenny; Mairead Kiely; Jonathan O'B Hourihane; Alan D Irvine; Zengru Wu; Yair Argon; Richard E Reitz; Michael J McPhaul; Adda Grimberg
Journal:  Horm Res Paediatr       Date:  2018-01-18       Impact factor: 2.852

3.  Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.

Authors:  Jessica M Faupel-Badger; Yuping Wang; S Ananth Karumanchi; Frank Stanczyk; Michael Pollak; Thomas McElrath; Robert N Hoover; Rebecca Troisi
Journal:  Cancer Causes Control       Date:  2011-09-24       Impact factor: 2.506

4.  Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factors.

Authors:  Jean A McDougall; Christopher I Li
Journal:  Horm Cancer       Date:  2010-02-06       Impact factor: 3.869

5.  Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life.

Authors:  Wan-yee Tang; Lisa M Morey; Yuk Yin Cheung; Lynn Birch; Gail S Prins; Shuk-mei Ho
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

6.  Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats.

Authors:  Kathirvel Gopalakrishnan; Jay S Mishra; Vijayakumar Chinnathambi; Kathleen L Vincent; Igor Patrikeev; Massoud Motamedi; George R Saade; Gary D Hankins; Kunju Sathishkumar
Journal:  Hypertension       Date:  2016-01-18       Impact factor: 10.190

7.  Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations.

Authors:  Kari A Weber; Christopher M Heaphy; Corinne E Joshu; Jiayun Lu; Sabine Rohrmann; Jessica L Bienstock; Tanya Agurs-Collins; Alan K Meeker; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2018-07-06       Impact factor: 2.506

8.  Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.

Authors:  Zhenwei Gu; Gang Wang; Weiguo Chen
Journal:  Tumour Biol       Date:  2014-03-01

Review 9.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

10.  Testosterone alters maternal vascular adaptations: role of the endothelial NO system.

Authors:  Vijayakumar Chinnathambi; Meena Balakrishnan; Jayanth Ramadoss; Chandrasekhar Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.